卫信康(603676) - 卫信康投资者关系活动记录表

Group 1: Company Overview - The company is Xizang Weixin Kang Pharmaceutical Co., Ltd. (Stock Code: 603676) [1] - The company focuses on the production of injectable multivitamins and other pharmaceutical products [2] Group 2: Market and Product Insights - As of January 2024, 9 provinces have announced the results of the centralized procurement for injectable multivitamins [2] - The sales revenue for various trace element injections in the first half of 2023 reached 86.93 million yuan, representing a year-on-year growth of 3.68% [2] Group 3: Research and Development - The company has over 40 major projects in research and development, focusing on differentiated products in areas such as trace elements, electrolytes, and amino acids [2][3] - The company emphasizes innovation and has a robust R&D system to enhance its core competitiveness [2] Group 4: Cost and Supply Chain Management - The fluctuation in raw material prices has a limited overall impact on the company's core products, which are developed using an API + formulation model [3] - The company is actively expanding its overseas business through partnerships and participation in international exhibitions [3]